BNP may help doctors identify HCM patients at highest risk of serious heart complications, improving monitoring and treatment ...

Scientists have developed a blood test that may help predict serious risks in people with hypertrophic cardiomyopathy, ...

Exclusive: Scientists find a way to forecast hypertrophic cardiomyopathy, which affects millions worldwide ...

The common genetic heart condition under the lens is hypertrophic cardiomyopathy (HCM). The problem is that there is no cure ...

Scientists are developing a blood test to identify individuals at high risk for hypertrophic cardiomyopathy (HCM), the ...

The AHA is expanding its initiative to improve detection, standardize care, and enhance treatment for hypertrophic cardiomyopathy.

"HCM is a heart muscle disease associated with a significant symptom burden. This approval of a new drug, Myqorzo, represents ...

Edgewise is now on track to deliver comprehensive efficacy and safety data from Part D of the mid-stage trial in the second ...

Edgewise announces completion of EDG-7500 CIRRUS-HCM phase 2 parts B & C and favourable interim safety results from the ongoing part D study in hypertrophic cardiomyopathy ...

Scientists have developed a simple blood test that can predict which heart disease patients face the greatest risk of ...

Hypertrophic cardiomyopathy is the most common hereditary heart disease worldwide. An international research team is now ...